Aspira Pathlab & Diagnostics standalone net profit rises 85.86% in the September 2025 quarter
Sales rise 30.91% to Rs 8.09 crore
Net profit of Aspira Pathlab & Diagnostics rose 85.86% to Rs 1.84 crore in the quarter ended September 2025 as against Rs 0.99 crore during the previous quarter ended September 2024. Sales rose 30.91% to Rs 8.09 crore in the quarter ended September 2025 as against Rs 6.18 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales8.096.18 31 OPM %27.1921.84 -PBDT2.241.35 66 PBT1.840.99 86 NP1.840.99 86Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 13 2025 | 2:17 PM IST